Full Text Journal Articles by
Author Marc Bosiers

Advertisement

Find full text journal articles






Assessment of 5-Year Mortality Outcomes for Femoropoliteal Interventions Using Drug-Eluting Devices in the REAL-PTX Study.

Tim Wittig, Thomas Zeller, Marc Bosiers, Patrick Peeters, Steffen Brucks, Yvonne Bausback, Andrej Schmidt, Dierk Scheinert, Sabine Steiner,

JACC Cardiovasc Interv (JACC. Cardiovascular interventions)
[2021, 14(10):1165-1168]

Cited: 0 times

View full text PDF listing >>



Heparin-Bonded Stent-Graft for the Treatment of TASC II C and D Femoropopliteal Lesions: 36-Month Results of the Viabahn 25 cm Trial.

Tanja Böhme, Elias Noory, Klaus Brechtel, Dierk Scheinert, Marc Bosiers, Ulrich Beschorner, Thomas Zeller,

<h4>Purpose</h4>To evaluate the 36-month technical and clinical outcome after implantation of the 25-cm Viabahn endoprosthesis with Propaten bioactive surface in TransAtlantic Inter-Society Consensus II C and D lesions of the superficial femoral and proximal popliteal arteries.<h4>Materials and methods</h4>This prospective, multicenter, single-arm trial (<i>ClinicalTrials.gov</i>; identifier NCT01263665) enrolled 71 patients (mean age ... Read more >>

J Endovasc Ther (Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists)
[2021, 28(2):222-228]

Cited: 0 times

View full text PDF listing >>



Advertisement

Stent-grafts are the best way to treat complex in-stent restenosis lesions in the superficial femoral artery: 24-month results from a multicenter randomized trial.

Marc Bosiers, Koen Deloose, Joren Callaert, Jürgen Verbist, Jeroen Hendriks, Patrick Lauwers, Herman Schroë, Wouter Lansink, Dierk Scheinert, Andrej Schmidt, Thomas Zeller, Ulrich Beschorner, Elias Noory, Giovanni Torsello, Martin Austermann, Jeroen Wauters,

<h4>Background</h4>This clinical trial aims to evaluate the outcome (up to 24-months) of the treatment of in-stent restenotic or reoccluded lesions in the femoropopliteal arteries, by comparing the treatment of the GORE<sup>®</sup> VIABAHN<sup>®</sup> Endoprosthesis with PROPATEN Bioactive Surface (W. L. Gore & Associates, Flagstaff, AZ, USA) with a standard PTA treatment. ... Read more >>

J Cardiovasc Surg (Torino) (The Journal of cardiovascular surgery)
[2020, 61(5):617-625]

Cited: 1 time

View full text PDF listing >>



Combining the Passeo-18 Lux Drug-Coated Balloon and the Pulsar-18 Bare Metal Stent: 12- and 24-Month Outcomes of the BIOLUX 4EVER Investigator-Initiated Trial.

Koen Deloose, Marc Bosiers, Patrick Peeters, Jürgen Verbist, Lieven Maene, Roel Beelen, Koen Keirse, Jeroen Hendriks, Patrick Lauwers, Jeroen Wauters, Merel Verschueren,

<h4>Purpose</h4>To report the outcomes after treating stenotic or occluded femoropopliteal lesions with a drug-coated balloon (DCB) followed by the implantation of a thin-strut self-expanding bare metal stent in the BIOLUX 4EVER trial (<i>ClinicalTrials.gov</i> identifier NCT02211664).<h4>Materials and methods</h4>The prospective, multicenter, physician-initiated BIOLUX 4-EVER trial was conducted at 5 centers in Belgium ... Read more >>

J Endovasc Ther (Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists)
[2020, 27(6):936-945]

Cited: 0 times

View full text PDF listing >>



Use of Dual-Layered Stents for Carotid Artery Angioplasty: 1-Year Results of a Patient-Based Meta-Analysis.

Eugenio Stabile, Gianmarco de Donato, Piotr Musialek, Koen Deloose, Roberto Nerla, Pasqualino Sirignano, Adam Mazurek, Wassim Mansour, Vincenzo Fioretti, Fabrizio Esposito, Salvatore Chianese, Marc Bosiers, Carlo Setacci, Francesco Speziale, Antonio Micari, Giovanni Esposito,

<h4>Objectives</h4>This study sought to evaluate 1-year safety and efficacy of dual-layered mesh-covered carotid stent systems (DLS) for carotid artery stenting (CAS).<h4>Background</h4>Small clinical studies evaluating 1-year outcomes of CAS performed with 2 available DLS, Roadsaver (RS) (Terumo Corp., Tokyo, Japan) and CGuard (CG) (InspireMD, Boston, Massachusetts), have been published.<h4>Methods</h4>The authors performed ... Read more >>

JACC Cardiovasc Interv (JACC. Cardiovascular interventions)
[2020, 13(14):1709-1715]

Cited: 1 time

View full text PDF listing >>



Three-Year Sustained Clinical Efficacy of Drug-Coated Balloon Angioplasty in a Real-World Femoropopliteal Cohort.

Giovanni Torsello, Konstantinos Stavroulakis, Marianne Brodmann, Antonio Micari, Gunnar Tepe, Pierfrancesco Veroux, Andrew Benko, Donghoon Choi, Frank E G Vermassen, Michael R Jaff, Jia Guo, Reka Dobranszki, Thomas Zeller, ,

<b>Purpose:</b> To report the 36-month outcomes from the prospective, multicenter, single-arm IN.PACT Global Study (<i>ClinicalTrials.gov</i> identifier NCT01609296) evaluating the performance of the IN.PACT Admiral drug-coated balloon (DCB) in real-world patients with femoropopliteal occlusive disease. <b>Materials and Methods:</b> The IN.PACT Global Study was conducted at 64 international sites and enrolled 1535 ... Read more >>

J Endovasc Ther (Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists)
[2020, 27(5):693-705]

Cited: 4 times

View full text PDF listing >>



One-year outcome of the paclitaxel-eluting Legflow balloon catheter in the treatment of long and complex femoropopliteal lesions.

Marc Bosiers, Koen Deloose, Giovanni Torsello, Dierk Scheinert, Jürgen Verbist, Wouter van den Eynde, Lieven Maene, Roel Beelen, Koen Keirse, Jeroen Hendriks, Joren Callaert, Michel Bosiers, Jeroen Wauters,

<h4>Background</h4>The aim of this study is to investigate the efficacy of the paclitaxel-eluting Legflow balloon catheter in the treatment of "real-world" long and complex femoropopliteal lesions.<h4>Methods</h4>The REFLOW study was a prospective, multi-national, non-randomized, single arm study evaluating the safety and efficacy of the Legflow paclitaxel-eluting balloon dilatation catheter in the ... Read more >>

J Cardiovasc Surg (Torino) (The Journal of cardiovascular surgery)
[2020, 61(4):471-477]

Cited: 0 times

View full text PDF listing >>



ZILVERPASS Study: ZILVER PTX Stent vs Bypass Surgery in Femoropopliteal Lesions.

Marc Bosiers, Carlo Setacci, Gianmarco De Donato, Giovanni Torsello, Pierre Galvagni Silveira, Koen Deloose, Dierk Scheinert, Pierfrancesco Veroux, Jeroen Hendriks, Lieven Maene, Koen Keirse, Tulio Navarro, Joren Callaert, Hans-Henning Eckstein, Jörg Teβarek, Alessia Giaquinta, Jeroen Wauters,

Purpose: To report the 12-month results of a multicenter, prospective, randomized controlled trial to determine if the ZILVER PTX paclitaxel-eluting stent was noninferior in terms of safety and efficacy compared with surgical bypass. Materials and Methods: This is a study in symptomatic TransAtlantic Inter-Society Consensus (TASC) C and D femoropopliteal ... Read more >>

J Endovasc Ther (Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists)
[2020, 27(2):287-295]

Cited: 0 times

View full text PDF listing >>



Clinical outcome after interventions with paclitaxel-coated balloons: a PCR statement.

Alexandra Lansky, Alberto Cremonesi, Bruno Scheller, Stefan James, Daniel Grubman, Jean Fajadet, Antoine Sauguet, Antonio Micari, Giovanna Sarno, Marc Bosiers, Andreas Baumbach, William Wijns,

EuroIntervention (EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology)
[2020, 15(14):1225-1227]

Cited: 0 times

View full text PDF listing >>



The IN.PACT DEEP Clinical Drug-Coated Balloon Trial: 5-Year Outcomes.

Thomas Zeller, Antonio Micari, Dierk Scheinert, Iris Baumgartner, Marc Bosiers, Frank E G Vermassen, Martin Banyai, Mehdi H Shishehbor, Hong Wang, Marianne Brodmann, ,

<h4>Objectives</h4>The goal of this study was to evaluate the 5-year follow-up data of the IN.PACT DEEP (Randomized IN.PACT Amphirion Drug-Coated Balloon [DCB] vs. Standard Percutaneous Transluminal Angioplasty [PTA] for the Treatment of Below-the-Knee Critical Limb Ischemia [CLI]) trial.<h4>Background</h4>Initial studies from randomized controlled trials have shown comparable short-term outcomes of DCB ... Read more >>

JACC Cardiovasc Interv (JACC. Cardiovascular interventions)
[2020, 13(4):431-443]

Cited: 2 times

View full text PDF listing >>



Final Two-Year Outcomes for the Sentry Bioconvertible Inferior Vena Cava Filter in Patients Requiring Temporary Protection from Pulmonary Embolism.

Michael D Dake, Timothy P Murphy, Albrecht H Krämer, Michael D Darcy, Luke E Sewall, Michael A Curi, Matthew S Johnson, Frank Arena, James L Swischuk, Gary M Ansel, Mitchell J Silver, Souheil Saddekni, Jayson S Brower, Robert Mendes, ,

<h4>Purpose</h4>To report final 2-year outcomes with the Sentry bioconvertible inferior vena cava (IVC) filter in patients requiring temporary protection against pulmonary embolism (PE).<h4>Materials and methods</h4>In a prospective multicenter trial, the Sentry filter was implanted in 129 patients with documented deep vein thrombosis (DVT) and/or PE (67.5%) or who were at ... Read more >>

J Vasc Interv Radiol (Journal of vascular and interventional radiology : JVIR)
[2020, 31(2):221-230.e3]

Cited: 0 times

View full text PDF listing >>



Paclitaxel-Coated Zilver PTX Drug-Eluting Stent Treatment Does Not Result in Increased Long-Term All-Cause Mortality Compared to Uncoated Devices.

Michael D Dake, Gary M Ansel, Marc Bosiers, Andrew Holden, Osamu Iida, Michael R Jaff, Aaron E Lottes, Erin E O'Leary, Alan T Saunders, Marc Schermerhorn, Hiroyoshi Yokoi, Thomas Zeller,

<h4>Purpose</h4>Patient-level data from two large studies of the Zilver PTX drug-eluting stent (DES) with long-term follow-up and concurrent non-drug comparator groups were analyzed to determine whether there was an increased mortality risk due to paclitaxel.<h4>Methods</h4>Data from the Zilver PTX randomized controlled trial (RCT) and Zilver PTX and bare metal stent ... Read more >>

Cardiovasc Intervent Radiol (Cardiovascular and interventional radiology)
[2020, 43(1):8-19]

Cited: 7 times

View full text PDF listing >>



Improvements in patient outcomes with next generation endovascular aortic repair devices in the ENGAGE Global Registry and the EVAR-1 clinical trial.

Dittmar Böckler, Adam H Power, Lee H Bouwman, Steven van Sterkenburg, Marc Bosiers, Patrick Peeters, Joep A Teijink, Hence J Verhagen, ,

<h4>Background</h4>The outcomes from the randomized controlled trials (RCTs) comparing endovascular aortic aneurysm repair (EVAR) to open surgical repair (OSR) may no longer be reflective of currently technology. Here the EVAR-1 trial and the ENGAGE registry are examined to assess potential improvements in outcomes with modern stent graft systems.<h4>Methods</h4>EVAR-1 was a ... Read more >>

J Cardiovasc Surg (Torino) (The Journal of cardiovascular surgery)
[2020, 61(5):604-609]

Cited: 0 times

View full text PDF listing >>



Editor's Choice - Five Year Outcomes of the Endurant Stent Graft for Endovascular Abdominal Aortic Aneurysm Repair in the ENGAGE Registry.

Joep A W Teijink, Adam H Power, Dittmar Böckler, Patrick Peeters, Steven van Sterkenburg, Lee H Bouwman, Hence J Verhagen, Marc Bosiers, Vincente Riambau, Jean-Pierre Becquemin, Philippe Cuypers, Marc van Sambeek,

<h4>Objective/background</h4>Endovascular abdominal aortic aneurysm repair (EVAR) is commonly used to treat abdominal aortic aneurysm (AAA). However, the incidence of long-term complications and the need for re-interventions after EVAR remain a concern. Newer generation stent grafts have encouraging short and mid-term outcomes, but thorough analysis of their long-term performance is necessary.<h4>Methods</h4>The ... Read more >>

Eur J Vasc Endovasc Surg (European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery)
[2019, 58(2):175-181]

Cited: 2 times

View full text PDF listing >>



Treatment algorithm for long segment femoropopliteal disease.

Marc Bosiers,

J Cardiovasc Surg (Torino) (The Journal of cardiovascular surgery)
[2019, 60(5):543-545]

Cited: 0 times

View full text PDF listing >>



One-year outcome of the everolimus-eluting, balloon-expandable Promus Element and Promus Element Plus stent in the treatment of below-the-knee lesions in CLI patients.

Kim Taeymans, Marc Bosiers, Koen Deloose, Joren Callaert, Koen Keirse, Jürgen Verbist, Wouter van den Eynde, Giovanni Torsello, Jeroen Wauters,

<h4>Background</h4>The aim of this study was to investigate the efficacy of the balloon expandable Promus Element and Promus Element Plus stents (both Boston Scientific, Marlborough, MA, USA), coated with everolimus, in the treatment of short, focal infrapopliteal lesions.<h4>Methods</h4>The PREVENT study was a prospective, multicenter, non-randomized, single arm study evaluating the ... Read more >>

J Cardiovasc Surg (Torino) (The Journal of cardiovascular surgery)
[2020, 61(4):445-450]

Cited: 0 times

View full text PDF listing >>



EVOLUTION Study: 12-month results.

Marc Bosiers, Koen Deloose, Joren Callaert, Patrick Peeters, Jürgen Verbist, Wouter van den Eynde, Lieven Maene, Roel Beelen, Koen Keirse, Jeroen Wauters,

BACKGROUND:The EVOLUTION Study is a prospective, non-randomized study, investigating the iVolution stent (iVascular, Barcelona, Spain). The study was conducted at the vascular departments of four hospitals in Belgium. This manuscript reports the findings up to 12-month follow-up time for the total cohort. The primary endpoint of the study is primary ... Read more >>

J Cardiovasc Surg (Torino) (The Journal of cardiovascular surgery)
[2019, 60(4):490-495]

Cited: 1 time

View full text PDF listing >>



Drug-Eluting Stent Versus Drug-Coated Balloon Revascularization in Patients With Femoropopliteal Arterial Disease.

Yvonne Bausback, Tim Wittig, Andrej Schmidt, Thomas Zeller, Marc Bosiers, Patrick Peeters, Steffen Brucks, Aaron E Lottes, Dierk Scheinert, Sabine Steiner,

<h4>Background</h4>Randomized trials of drug-eluting stents (DES) and drug-coated balloons (DCB) for femoropopliteal interventions reported superior patency rates for both strategies compared to standard balloon angioplasty. To date, head-to-head comparisons are missing.<h4>Objectives</h4>The authors sought to compare DES versus DCB for femoropopliteal lesions through 36 months.<h4>Methods</h4>Within a multicenter, randomized trial, 150 patients with ... Read more >>

J Am Coll Cardiol (Journal of the American College of Cardiology)
[2019, 73(6):667-679]

Cited: 4 times

View full text PDF listing >>



Evaluation of a new dual-layer micromesh stent system for the carotid artery: 12-month results from the CLEAR-ROAD study.

Marc Bosiers, Koen Deloose, Giovanni Torsello, Dierk Scheinert, Lieven Maene, Patrick Peeters, Stefan Müller-Hülsbeck, Horst Sievert, Ralf Langhoff, Joren Callaert, Carlo Setacci, Jeroen Wauters,

EuroIntervention (EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology)
[2018, 14(10):1144-1146]

Cited: 1 time

View full text PDF listing >>



Use of Dual-Layered Stents in Endovascular Treatment of Extracranial Stenosis of the Internal Carotid Artery: Results of a Patient-Based Meta-Analysis of 4 Clinical Studies.

Eugenio Stabile, Gianmarco de Donato, Piotr Musialek, Koen De Loose, Roberto Nerla, Pasqualino Sirignano, Salvatore Chianese, Adam Mazurek, Tullio Tesorio, Marc Bosiers, Carlo Setacci, Francesco Speziale, Antonio Micari, Giovanni Esposito,

<h4>Objectives</h4>The aim of this study was to evaluate the clinical efficacy of dual-layered mesh-covered carotid stent systems (DLS) for carotid artery stenting (CAS).<h4>Background</h4>The need to minimize the risk for plaque debris prolapsing between stent struts following CAS has resulted in the development of DLS. Small clinical studies evaluating 2 available ... Read more >>

JACC Cardiovasc Interv (JACC. Cardiovascular interventions)
[2018, 11(23):2405-2411]

Cited: 5 times

View full text PDF listing >>



One-Year Analysis of the Prospective Multicenter SENTRY Clinical Trial: Safety and Effectiveness of the Novate Sentry Bioconvertible Inferior Vena Cava Filter.

Michael D Dake, Timothy P Murphy, Albrecht H Krämer, Michael D Darcy, Luke E Sewall, Michael A Curi, Matthew S Johnson, Frank Arena, James L Swischuk, Gary M Ansel, Mitchell J Silver, Souheil Saddekni, Jayson S Brower, Robert Mendes, ,

<h4>Purpose</h4>To prospectively assess the Sentry bioconvertible inferior vena cava (IVC) filter in patients requiring temporary protection against pulmonary embolism (PE).<h4>Materials and methods</h4>At 23 sites, 129 patients with documented deep vein thrombosis (DVT) or PE, or at temporary risk of developing DVT or PE, unable to use anticoagulation were enrolled. The ... Read more >>

J Vasc Interv Radiol (Journal of vascular and interventional radiology : JVIR)
[2018, 29(10):1350-1361.e4]

Cited: 1 time

View full text PDF listing >>



Anterograde or retrograde arterial access for diabetic limb revascularization.

Marc Bosiers, Koen Deloose, Joren Callaert,

The selection of an optimal vascular access strategy for lower limb endovascular intervention is key for procedural safety and success, and is particularly relevant in diabetic patients, in whom extensive occlusive disease commonly involves the infrapopliteal arteries. Individualizing vascular access requires careful planning, including determining normal and abnormal arterial anatomy; ... Read more >>

Semin Vasc Surg (Seminars in vascular surgery)
[2018, 31(2-4):76-80]

Cited: 1 time

View full text PDF listing >>



How to compare results from open with endovascular procedures?

Marc Bosiers, Koen Deloose, Joren Callaert, Patrick Peeters, Jeroen Wauters,

BACKGROUND:According to the guidelines, bypass surgery is still the golden standard treatment in patients with femoropopliteal TASC C and D lesions and life-style limiting claudication or critical limb ischemia. Over the past few decades, endovascular therapy has made great advancements. However, the success rates of surgical and endovascular procedures cannot ... Read more >>

J Cardiovasc Surg (Torino) (The Journal of cardiovascular surgery)
[2020, 61(2):196-199]

Cited: 0 times

View full text PDF listing >>



Nine-Month Outcomes of the DURABILITY Iliac Study on Self-Expanding Stents for Symptomatic Peripheral Artery Disease.

Peter Faries, Michael Jaff, Patrick Peeters, Yazan Khatib, David Roberts, Marc Bosiers, Rajesh Malik, Reid Ravin, John Rundback,

<h4>Background</h4>The DURABILITY Iliac clinical study evaluated the safety and effectiveness of 2 nitinol self-expanding stents for the treatment of atherosclerotic common and external iliac artery lesions up to 10 cm in length and >50% stenosis in subjects with Rutherford classification peripheral arterial disease stages 2-4.<h4>Methods</h4>DURABILITY Iliac was a prospective, multicenter, core ... Read more >>

Ann Vasc Surg (Annals of vascular surgery)
[2018, 51:37-47]

Cited: 0 times

View full text PDF listing >>



Drug-Coated Balloon Treatment of Femoropopliteal Lesions for Patients With Intermittent Claudication and Ischemic Rest Pain: 2-Year Results From the IN.PACT Global Study.

Antonio Micari, Marianne Brodmann, Koen Keirse, Patrick Peeters, Gunnar Tepe, Martin Frost, Hong Wang, Thomas Zeller, ,

OBJECTIVES:The IN.PACT Global Study is the largest prospective, multicenter, independently adjudicated trial to evaluate a paclitaxel drug-coated balloon in patients with lifestyle-limiting claudication and/or ischemic rest pain due to atherosclerotic disease of the femoropopliteal artery and includes complex lesions beyond what are typically included in randomized controlled trials. BACKGROUND:Randomized controlled ... Read more >>

JACC Cardiovasc Interv (JACC. Cardiovascular interventions)
[2018, 11(10):945-953]

Cited: 12 times

View full text PDF listing >>



Advertisement

Disclaimer
1.618 s